Kanokorn Lerdlamyong
Overview
Explore the profile of Kanokorn Lerdlamyong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
38
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wangchinda W, Laohasakprasit K, Lerdlamyong K, Thamlikitkul V
Infect Drug Resist
. 2022 Oct;
15:2199-2210.
PMID: 36312438
Purpose: To investigate the epidemiology of carbapenem-resistant (CRE) colonization or CRE infection relative to the natural history and clinical course of CRE colonization or CRE infection in hospitalized patients during...
2.
Rattanaumpawan P, Jirajariyavej S, Lerdlamyong K, Palavutitotai N, Saiyarin J
Antibiotics (Basel)
. 2022 Jun;
11(6).
PMID: 35740211
Favipiravir is a broad-spectrum oral antiviral agent that shows in vitro activity against SARS-CoV-2. Presently, data on the real-world effectiveness and optimal dosage of favipiravir for treating COVID-19 are limited....
3.
Boonyasiri A, Jauneikaite E, Brinkac L, Greco C, Lerdlamyong K, Tangkoskul T, et al.
BMC Infect Dis
. 2021 Feb;
21(1):142.
PMID: 33541274
Background: Infections caused by carbapenemase-producing Enterobacteriaceae (CPE) have continually grown as a global public health threat, with significant mortality rates observed across the world. We examined the clinical data from...
4.
Lerdlamyong K, Sukpanichnant S, Rattanaumpawan P
Br J Haematol
. 2017 Jan;
176(6):849.
PMID: 28106902
No abstract available.